Dexcom | DXCM - 판매 매출 총 이익

주가
62.28
매일 변경
2.76 4.64%
매월
-0.83%
매년
-11.36%
Q2 예상
60.25




판매 매출 총 이익 변화 날짜
Abbott USD 5.86B 675M 2026-03
Align Technology USD 736.59M 53M 2026-03
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 535.95M 49.28M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
J&J USD 17.24B 642M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Solventum Corp USD 1.03B 108M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
West Pharmaceutical Services USD 296.4M 7.5M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12